Search
Home
Agenda
Speakers
Companies
Sponsors
Yelp Guide
Blog/News
Session Feedback
Browse
Attendee
×
×
×
Dan Barber
Position
Chief Operating Officer
Company
Aquestive Therapeutics
Networks
Website
Bio
None provided.
Agenda
Value‚ Patient Access and Reimbursement
How to Ensure Access Doesn’t Get in the Way of Good Science
111AB, Level 100
Bryan Katz
Vice President, Syneos One at
Syneos Health
Dan Barber
Chief Operating Officer at
Aquestive Therapeutics
Dr. John Doyle
Vice President, Global Healthcare Innovation Lead at
Pfizer Inc.
Martin Marciniak
Vice President, U.S. Medical Affairs, Customer Engagement, Value, Evidence & Outcomes at
GlaxoSmithKline
Mr. James Shaffer
Chief Business Officer at
Eiger BioPharmaceuticals
Interests
Interest Area
Drug Delivery
,
Interest Area
Neurological Disease
,
Interest Area
Opioids
,
Interest Area
Orphan & Rare Diseases
,
Interest Area
Pain Management
,
Interest Area
Therapeutics
,
Session Tracks
Business Development And Finance
,
Session Tracks
Emerging Opportunities In Global Markets
,
Session Tracks
Intellectual Property
,
Session Tracks
Orphan And Rare Diseases
,
Session Tracks
Patient Advocacy